Amgen (AMGN) Inventory Average (2009 - 2026)
Amgen (AMGN) posted quarterly Inventory Average of $6.2 billion for Q1 2026, down 9.59% year-over-year from $6.9 billion in Q1 2025, and down 1.27% quarter-over-quarter from $6.3 billion in Q4 2025.
Amgen (AMGN) Inventory Average (2009 - 2026) Analysis & Trends
Amgen's Inventory Average history runs 17 years deep, the most recent figure standing at $6.2 billion for Q1 2026.
- In Q1 2026, Inventory Average fell 9.59% year-over-year to $6.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (down 9.59% YoY), while the FY2025 annual figure was $6.6 billion, down 19.94% from the prior year.
- Inventory Average for Q1 2026 stood at $6.2 billion, down from $6.3 billion in the prior quarter.
- The five-year high for Inventory Average was $9.1 billion in Q1 2024, with the low at $4.2 billion in Q1 2022.
- The 5-year median for Inventory Average is $6.3 billion (2025), against an average of $6.2 billion.
- The sharpest annual moves came in 2024 and 2025: Inventory Average soared 83.5% in 2024, then declined 24.75% in 2025.
- Amgen's Inventory Average stood at $4.8 billion in 2022, then soared by 50.14% to $7.3 billion in 2023, then slipped by 1.27% to $7.2 billion in 2024, then declined by 12.46% to $6.3 billion in 2025, then declined by 1.27% to $6.2 billion in 2026.
- Business Quant data shows AMGN's Inventory Average at $6.2 billion in Q1 2026, $6.3 billion in Q4 2025, and $6.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.20 Bn |
| Mar 31, 2026 | 6.21 Bn |
| Dec 31, 2025 | 6.29 Bn |
| Sep 30, 2025 | 6.46 Bn |
| Jun 30, 2025 | 6.66 Bn |
| Mar 31, 2025 | 6.86 Bn |
| Dec 31, 2024 | 7.18 Bn |
| Sep 30, 2024 | 7.68 Bn |
| Jun 30, 2024 | 8.36 Bn |
| Mar 31, 2024 | 9.12 Bn |
| Dec 31, 2023 | 7.27 Bn |
| Sep 30, 2023 | 5.00 Bn |
| Jun 30, 2023 | 4.99 Bn |
| Mar 31, 2023 | 4.97 Bn |
| Dec 31, 2022 | 4.84 Bn |
| Sep 30, 2022 | 4.66 Bn |
| Jun 30, 2022 | 4.48 Bn |
| Mar 31, 2022 | 4.25 Bn |
| Dec 31, 2021 | 4.12 Bn |
| Sep 30, 2021 | 4.13 Bn |